Using our MedAITM service, we help solution providers to streamline research and development by combining learning from data with learning from worldwide evidence in medicine and health.
including PhDs in AI/ML for -omics and public health from top UK universities.
scientific programmers, AI backend developers, full-stack developers.
primary care physicians, medical consultants, patient support charities.
clinical researchers, health economists, regulatory specialists.
editors of clinical journals, directors of clinical guidelines, professors of medicine, professors of AI and machine learning from some of the world-leading universities.
Based on this work, we were able to draw a comparison of our evidence-based approach (MedAITM) and an incumbent auto-ML platform (denoted "AutoAI") by a company with capitalization >$1B. [Joint work of Pharmatics, NHS GGC, MWDH Limited, 2021]